Treatment and plan are confirmed after your assessment.
A licensed provider reviews your health history and determines whether treatment is appropriate for you.
Step 01IGF-1 LR3 is administered through a subcutaneous injection, which delivers the modified insulin-like growth factor directly into the fatty tissue layer beneath the skin. From this injection site, the long-acting form of IGF-1 is gradually absorbed into the bloodstream, where its extended structure allows it to remain active longer than natural IGF-1.
Step 02Once in circulation, IGF-1 LR3 binds to IGF-1 receptors located on the surface of muscle, bone, and other tissue cells throughout the body. This modified version has reduced binding to IGF binding proteins, allowing it to remain bioavailable and active for extended periods. The receptor binding triggers intracellular signaling cascades that promote cellular growth and development.
Step 03After receptor activation, IGF-1 LR3 stimulates protein synthesis within cells, promoting muscle tissue growth and repair. It enhances glucose and amino acid uptake into cells, providing the building blocks needed for new tissue formation. This anabolic effect supports muscle recovery, promotes lean tissue development, and may enhance overall cellular regeneration in targeted tissues.
From your first assessment to the next step in your care.
Complete an online assessment about your goals, health history, and current routine.
A licensed provider reviews your information and determines whether treatment is appropriate for you.
Review your treatment plan and use your patient account to manage consultations, orders, and messages.
Learn more about this treatment and what to expect from your care.
